 | Zentalis Pharmaceuticals, Inc. | |||
| NGM : ZNTL || Location: United States | ||||
$11.06+0.08 (+0.68%) |
0.47 M | 10.77 - 11.23 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 16.638 M |
| March 28, 2024 | 15.528 M |
| March 15, 2024 | 16.735 M |
| Feb. 29, 2024 | 14.560 M |
| Feb. 15, 2024 | 14.328 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.93 | -0.93 | 0.45% |
| 09/30/2023 | -0.93 | -0.79 | 15.04% |
| 06/30/2023 | -1.06 | -1.85 | -74.81% |
| 03/31/2023 | -1.04 | -1.07 | -2.90% |
| 12/31/2022 | -1.08 | -0.92 | 14.92% |
ZNTL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 70.960M | Shares Float | 50.352M |
| Short Float | 16.638M | Market Cap | 779.14M |
| Institution ownership | 0.00% | Insider ownership | 4.272% |
| Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -4.47 | Forward EPS | -3.77 |